Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Liposome (VS-1024-FY97) (CAT#: VS-1024-FY97)

The application of anti-FLT1 antibody-conjugated liposomes in glioma may provide a more targeted treatment option. By targeting the FLT1 protein, this therapeutic approach can enhance the accumulation of drugs at the tumor site, thereby improving efficacy. Future clinical trials will help verify its safety and effectiveness, bringing new hope to glioma patients.

Sub Cat Product Name Liposome Name Datasheet  
VS-1124-FY1633 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Gd-SLs Liposome (VS-1124-FY1633) Gd-SLs liposome
VS-1124-FY1634 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled PEGylated Liposome (VS-1124-FY1634) PEGylated liposome
VS-1124-FY1635 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Triptolide-loaded Liposome (VS-1124-FY1635) Triptolide-loaded liposome
VS-1124-FY1636 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Phospholipid Liposome (VS-1124-FY1636) Phospholipid liposome
VS-1124-FY1637 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Cationic Liposome (VS-1124-FY1637) Cationic liposome
VS-1124-FY1638 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Adriamycin-encapsulated Liposome (VS-1124-FY1638) Adriamycin-encapsulated liposome
VS-1124-FY1639 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Magnetofluorescent Liposome (VS-1124-FY1639) Magnetofluorescent liposome
VS-1124-FY1640 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled pH-sensitive Liposome (VS-1124-FY1640) pH-sensitive liposome
VS-1124-FY1641 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Phototoxic Liposome (VS-1124-FY1641) Phototoxic liposome
VS-1124-FY1642 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Targeted Liposome (VS-1124-FY1642) Targeted Liposome
VS-1124-FY1643 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Apt1-Liposome (VS-1124-FY1643) Apt1-liposome
VS-1124-FY1644 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Thermosensitive Liposome (VS-1124-FY1644) Thermosensitive liposome
VS-1124-FY1645 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Clodronate Liposome (VS-1124-FY1645) Clodronate liposome
VS-1124-FY1646 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Galcer Liposome (VS-1124-FY1646) Galcer liposome
VS-1124-FY1647 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled HBsAg-loaded Liposome (VS-1124-FY1647) HBsAg-loaded liposome
VS-1124-FY1648 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled Phospholipid Liposome and Cationic Liposome (VS-1124-FY1648) Phospholipid liposome and Cationic liposome
VS-1124-FY1649 Anti-FLT1 (clone 18F1) Recombinant Antibody Coupled ISMN Liposome (VS-1124-FY1649) ISMN liposome
More Infomation
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Potential Clinical Applications
  • Glioma

Product Composition

  • Clone
  • 18F1
  • Antibody Type
  • IgG
  • Antibody Host
  • Human
  • Antibody Reactivity
  • Human
  • Antibody Description
  • This is a recombinant human monoclonal antibody that was designed to selectively bind to the human FLT1 (Fms-like tyrosine kinase 1) receptor. FLT1 is primarily involved in the regulation of angiogenesis and vasculogenesis, playing a crucial role in the development of blood vessels. By specifically targeting FLT1, this monoclonal antibody can potentially inhibit excessive vascular growth and contribute to therapeutic strategies for various diseases characterized by abnormal blood vessel formation, such as cancer and inflammatory disorders.

Product Property

  • Storage
  • See in the COA
  • Storage Shelf Time
  • See in the COA

Target Information

  • Target
  • FLT1
  • Introduction
  • This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.
  • Alternative Names
  • Fms Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-Related Tyrosine Kinase 1 (Vascular Endothelial Growth Factor/Vascular Permeability Factor Receptor); Vascular Endothelial Growth Factor Receptor 1; Tyrosine-Protein Kinase Receptor FLT; Tyrosine-Protein Kinase FRT; Fms-Like Tyrosine Kinase 1
  • Full Name
  • Fms Related Tyrosine Kinase 1
  • Sequence Similarities
  • Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
  • Cellular Localization
  • Cell membrane; Single-pass type I membrane protein
    Endosome
  • Post Translation Modifications
  • N-glycosylated.
    Ubiquitinated after VEGFA-mediated autophosphorylation, leading to proteolytic degradation.
    Autophosphorylated on tyrosine residues upon ligand binding.
  • Function
  • Acts as a positive regulator of postnatal retinal hyaloid vessel regression (By similarity).
    May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells.
    Can promote endothelial cell proliferation, survival and angiogenesis in adulthood.
    Its function in promoting cell proliferation seems to be cell-type specific.
    Promotes PGF-mediated proliferation of endothelial cells, proliferation of some types of cancer cells, but does not promote proliferation of normal fibroblasts (in vitro).
    Has very high affinity for VEGFA and relatively low protein kinase activity; may function as a negative regulator of VEGFA signaling by limiting the amount of free VEGFA and preventing its binding to KDR.
    Modulates KDR signaling by forming heterodimers with KDR.
    Ligand binding leads to the activation of several signaling cascades.
    Activation of PLCG leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C.

Related Resources

  • Related Diseases

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 18F1"

See other products for "FLT1"

Select a product category from the dropdown menu below to view related products.
Please select product type
ScFv Antibody Products Human Antibody Products Mouse Antibody Products Chimeric Antibody Products IgG Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products MHC Tetramer Products for Cancer

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-1024-FY97. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare